title: Inability of OKT3 to prevent donor-derived ABO hemolytic anemia in a kidney-pancreas transplant recipient.
authors.forename: J M
authors.initials: JM
authors.lastname: Doutrelepont
authors.forename: D
authors.initials: D
authors.lastname: Abramowicz
authors.forename: M
authors.initials: M
authors.lastname: Lambermont
authors.forename: P
authors.initials: P
authors.lastname: Kinnaert
authors.forename: J L
authors.initials: JL
authors.lastname: Vanherweghem
authors.forename: P
authors.initials: P
authors.lastname: Vereerstraeten
authors.forename: M
authors.initials: M
authors.lastname: Goldman
authors.forename: L
authors.initials: L
authors.lastname: De Pauw
mesh_terms: D000328:Adult; D000743:Anemia, Hemolytic / Q000209:etiology* / Q000517:prevention & control; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects*; D008297:Male; D016853:Muromonab-CD3 / Q000008:administration & dosage*; D016035:Pancreas Transplantation / Q000009:adverse effects*
chemical_list: D016853:Muromonab-CD3